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Editorial
The number of organisms with completed genome
sequences continues to grow rapidly, and the past year has
seen the completion of several major eukaryotic genomes,
including those of the chicken and rat as well as the first
chimpanzee chromosome. The addition of new species,
such as Drosophila pseudoobscura, the pufferfish
Tetraodon nigroviridi and the nematode Caenorhabditis
briggsae, all of which have close relatives whose genomes
had already been sequenced (Drosophila melanogaster,
Takifugu rubripes and Caenorhabditis elegans, respectively),
has allowed further demonstrations of the power of com-
parative genomics for genome annotation and evolutionary
studies. While the advantages of free and unfettered access
to sequence data are evident from the ever-increasing
number of studies that make use of public sequence databases,
the question of how to give access to publications of
genomic and other scientific data continues to be the
subject of much debate.
Following an overwhelming vote by the US House of Repre-
sentatives urging the National Institutes of Health (NIH)
to develop an Open Access strategy, NIH invited comment
on its plans to enhance access to the research that it
funds. Under the NIH proposal, NIH-funded researchers
would have to provide electronic copies of the final
accepted versions of each of their manuscripts, for archiving
along with any supplementary information in PubMed
Central [http://www.pubmedcentral.nih.gov]. Six months
after publication of the research in question - or sooner if
the publisher agrees - the provisional copies will be made
publicly available at no charge to readers. NIH is now sub-
mitting a final version of its policy to the US Congress.  
Genome Biology heartily supports the NIH proposal,
which brings us one step closer to the immediate availability
of all peer-reviewed research free of charge. Indeed, as
Open Access pioneers, BioMed Central and Genome
Biology already provide PubMed Central with final full
text and PDF versions of all research articles immediately
on publication, and we encourage all publishers to follow
suit. In an ideal future, the electronic version of each
research article would be the final and definitive form -
easily archived, centrally searchable and available at the
click of a mouse to all who would read it, be they scientists
or members of the public. Of course, print would still play
an important role, but printed articles will no longer con-
stitute the historic record of the work. And moving away
from the printed article in favor of its online incarnation
makes sense for other reasons too: electronically,
researchers can display all relevant data instead of an
edited subset, and moving images and other web-only
formats can be easily integrated. It will no longer be possible
to represent a complete research article accurately on the
printed page. 
As many readers know, Genome Biology has always presented
its research articles in a way that differs from traditional
journals: each printed issue serves to draw readers' attention
to the definitive online content on the journal's website (or
in central archives such as PubMed Central), where original
research articles are freely available to all readers and no
restrictions apply on the number of pages or the kinds of
datasets that can be presented. In the world of genomics
the rapid and easy publication of large datasets has been
particularly important. Many researchers have taken
advantage of Genome Biology's Open Access policy, and
the number of submissions of original research articles to
Genome Biology (and the number of such articles published)
has risen continually since the journal's launch. Genome
Biology and its publisher, BioMed Central, are committed
to building a sustainable Open Access business model. This
should primarily ensure that research articles are immediately
and permanently available online without charge, as well
as being deposited into permanent repositories - both of
which provide far more efficient ways of disseminating,
retrieving, and searching for scientific information. For this
reason, in 2003 the journal introduced a standard process-
ing charge that is levied on research articles accepted for
publication, so as to cover the costs associated with making
the article freely and universally accessible online (see
[http://genomebiology.com/information/about/apcfaq.asp]).
Genome Biology urges other funding bodies and policy
makers to follow the lead of the NIH, the Science and
Technology Committee of the UK Parliament, the Howard
Hughes Medical Institute, The Wellcome Trust and the
signatories of the Berlin Declaration [http://www.zim.mpg.de/
openaccess-berlin], and to encourage the researchers they
fund to publish their results in a way that promotes public
availability of scientific information. At the same time, it
should be recognized that we still have a long way to go
before every research article is free for anyone to read
online on the day it is published: even articles describing
the genome sequences of important organisms are still
submitted to journals that restrict access to the analysis
and description of the genomic data, so that only subscribers
can read the analysis. You can play your part in overcoming
these restrictions by submitting your next important
article to Genome Biology.
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